Yunnan Botanee Bio-Technology Group Co Ltd Total Liabilities
Yunnan Botanee Bio-Technology Group Co Ltd total liabilities. Based on the latest financial reports, Yunnan Botanee Bio-Technology Group Co Ltd (300957) has total liabilities worth CN¥1.95 Billion CNY (≈ $285.35 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Yunnan Botanee Bio-Technology Group Co L (300957) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Yunnan Botanee Bio-Technology Group Co Ltd (2017–2025)
Total liabilities of Yunnan Botanee Bio-Technology Group Co Ltd from 2017 to 2025. This chart illustrates how Yunnan Botanee Bio-Technology Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Yunnan Botanee Bio-Technology Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Yunnan Botanee Bio-Technology Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Iluka Resources Limited
F:ILZ
|
Germany | €2.15 Billion |
|
Sparebanken Vest
OL:SVEG
|
Norway | Nkr319.85 Billion |
|
Lianhe Chemical Technology Co Ltd
SHE:002250
|
China | CN¥6.70 Billion |
|
Central Puerto S.A.
BA:CEPU
|
Argentina | AR$1.87 Trillion |
|
SK Bioscience Co Ltd
KO:302440
|
Korea | ₩847.96 Billion |
|
Hengdian Group Tospo Lighting Co Ltd
SHG:603303
|
China | CN¥2.51 Billion |
|
Jiangnan Mould & Plastic Technology Co Ltd
SHE:000700
|
China | CN¥3.09 Billion |
|
Astronics Corporation
NASDAQ:ATRO
|
USA | $566.60 Million |
Liability Composition Analysis (2017–2025)
This chart breaks down Yunnan Botanee Bio-Technology Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 300957 total asset value.
Liquidity & Leverage Metrics
Yunnan Botanee Bio-Technology Group Co Ltd Total Liabilities Ratios Explained
Yunnan Botanee Bio-Technology Group Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.84 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Yunnan Botanee Bio-Technology Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2025)
The table below shows the annual total liabilities of Yunnan Botanee Bio-Technology Group Co Ltd from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥2.04 Billion ≈ $298.05 Million |
-3.73% |
| 2024-12-31 | CN¥2.12 Billion ≈ $309.60 Million |
+41.89% |
| 2023-12-31 | CN¥1.49 Billion ≈ $218.20 Million |
+33.46% |
| 2022-12-31 | CN¥1.12 Billion ≈ $163.49 Million |
+8.05% |
| 2021-12-31 | CN¥1.03 Billion ≈ $151.31 Million |
+114.74% |
| 2020-12-31 | CN¥481.52 Million ≈ $70.46 Million |
+49.16% |
| 2019-12-31 | CN¥322.82 Million ≈ $47.24 Million |
+3.10% |
| 2018-12-31 | CN¥313.11 Million ≈ $45.82 Million |
+30.79% |
| 2017-12-31 | CN¥239.40 Million ≈ $35.03 Million |
-- |
About Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. It operates through Skin Care Products, Medical Instruments, and Makeup segments. The company offers face creams, toners, masks, serums, and lotions; and makeup products, including primers, powders, BB creams, and makeup … Read more